Last $2.35 USD
Change Today +0.04 / 1.73%
Volume 20.1K
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph V. Gulfo M.D., M.B.A.

Former Chairman, Chief Executive Officer and President, MELA Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 2 different industries.

See Board Relationships
51$1,418,114
As of Fiscal Year 2013

Background*

Dr. Joseph V. Gulfo M.D., M.B.A served as the Chief Executive Officer and President of MELA Sciences, Inc. from January 2004 to June 15, 2013. From May 1999 to November 2004, Dr. Gulfo served as Chairman, Chief Executive Officer and President of Antigen Express, Inc., a development-stage company developing immunodiagnostics and therapeutics for cancer. Dr. Gulfo has significant experience in the management and development of biopharmaceutical companies and products. ...

Read Full Background

Corporate Headquarters*

50 South Buckhout Street
Irvington, New York 10533

United States

Phone: 914-591-3783
Fax: 914-591-3785

Board Members Memberships*

Director
2004-2013
Former Chairman, Chief Executive Officer and President

Education*

MD
University of Medicine and Dentistry of New Jersey
BS
Seton Hall University
MBA
Seton Hall University

Other Affiliations*

Annual Compensation*

Salary$179,722
Total Annual Compensation$179,722

Stock Options*

All Other Compensation$5,392

Total Compensation*

Total Annual Cash Compensation$185,114
Total Short Term Compensation$179,722
Other Long Term Compensation$5,392
Total Calculated Compensation$1,418,114
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MELA:US $2.35 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Anthony S. Marucci M.B.A.Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$871.4K
Thomas A. Braun BA, J.D., LLMChief Executive Officer, President, Director, Member of Compensation Committee and Member of Audit Committee
Verisante Technology, Inc.
C$312.5K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MELA SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.